Table 2 Demographic and clinical characteristics of study participants
From: Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study
PD (n = 65) | Control (n = 27) | |
|---|---|---|
Male/female (n) | 48/17 | 19/8 |
Age (years) | 66.2 ± 9.4 | 68.7 ± 9.6 |
Education (years) | 12.8 ± 2.9 | 13.4 ± 2.9 |
MMSE | 28.0 ± 2.7 | 29.0 ± 1.1 |
MoCA | 23.9 ± 5.1 | 27.0 ± 1.9 |
Symptom duration (years) | 6.3 ± 5.7 | |
range | 0.5-30 | |
UPDRS part III | 33.7 ± 16.3 | - |
Modified H & Y stage (median) | 2.5 | |
range | 1–4 | |
Cognitive status (n) | ||
Unimpaired | 41 | 27 |
MCI | 14 | |
Dementia | 10 | |
PD Medication Status (n) | ||
No medication | 24 | |
On Medication | 41 | |
LED (mg/day) | 572.4 ± 339.5 |